tility of the nasal high flow oxygen therapy in bronchoscopy.
Not Applicable
- Conditions
- The patients who will receive bronchoscopic examination with or without an obstructive lung disease, a restrictive lung disease, and/or hypoxemia.
- Registration Number
- JPRN-UMIN000009587
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with pneumothorax 2. The type 2 respiratory failure patient who needs respirator management. 3. The patient who has difficulty in oxygen dosage from a nose. 4. If the patient's written consent cannot be obtained. 5. Patients judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Utility 1: Changes of SpO2 of the patients during bronchoscopy. 2: The rate of inspection discontinuation. 2) Safety 1: The period of bronchoscopic examination. 2: The percentage of pneumothorax, and necessary of mechanical ventilation.
- Secondary Outcome Measures
Name Time Method